Pharmaceuticals

Antivirals Market Size Forecast: Revenue and CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Antivirals Industry In 2025?

The antivirals market has experienced significant growth in recent years. It is anticipated to expand from $106.64 billion in 2024 to $114.4 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. The expansion observed historically can be attributed to factors such as the prevalence of viral diseases, public health concerns, patent expirations, and various government initiatives.

The antivirals market is projected to experience substantial expansion over the coming years. Its size is predicted to reach $151.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This anticipated growth is primarily driven by factors such as emerging viral threats and global health initiatives. Key trends anticipated during this period encompass technological advances, the rise of telemedicine and digital health solutions, and personalized medicine approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Are The Top Growth Drivers Impacting The Antivirals Market Outlook?

The growing incidence of influenza is projected to propel the antiviral market’s expansion. Influenza, often referred to as the flu, constitutes a highly transmissible viral respiratory infection, brought on by influenza viruses that impact the nose, throat, and lungs. Antivirals are utilized to treat influenza, functioning to inhibit the replication and internal spread of influenza viruses. For example, in October 2022, the Centers for Disease Control and Prevention, a US-based health agency, reported 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths during the 2021-2022 season. Thus, the rising prevalence of influenza is directly contributing to the growth of the antiviral market.

What Are The Key Segments In The Antivirals Market?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Which Market Trends Are Creating New Opportunities In The Antivirals Industry?

Leading companies within the antiviral market are concentrating on developing innovative remedies like oral antiviral treatments. This focus aims to enhance patient compliance, broaden accessibility, reduce healthcare expenses, and offer more convenient and effective methods for managing viral infections. Oral antiviral treatment refers to medications taken by mouth specifically to treat viral infections. These treatments function by inhibiting viruses from replicating or spreading within the body, thereby helping to diminish the infection’s severity and duration. For instance, in May 2023, Pfizer, a US-based pharmaceutical company, announced that Paxlovid had received approval, establishing it as the first oral antiviral treatment for COVID-19 in adults by the Food and Drug Administration, a US-based government agency. This approval is especially significant as it presents a new therapeutic option for handling COVID-19, particularly in a period where the pandemic is transitioning toward an endemic phase. Paxlovid is specifically indicated for adults with mild-to-moderate COVID-19 who are at high risk for progression to severe disease, including hospitalization or death.

Who Are The Core Companies Influencing The Antivirals Market Landscape?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

How Is Antivirals Market Demand Varying Across Different Regions?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Antivirals Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Browse Through More Reports Similar to the Global Antivirals Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795